Literature DB >> 17097969

Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation.

J A Perez-Daga1, J Santoyo, M A Suárez, J A Fernández-Aguilar, C Ramírez, A Rodríguez-Cañete, J M Aranda, B Sánchez-Pérez, C Montiel, D Palomo, M Ruiz, A Mate.   

Abstract

The aim of this study was to evaluate the impact on initial graft function of the degree of steatosis detected in the back-table biopsy, and its repercussion on the clinical results of the transplant (early posttransplant mortality and morbidity). We undertook a retrospective analysis of 300 liver transplants performed at our center from 1997 to 2004. A wedge liver biopsy was done routinely during back-table surgery (available in 294 transplants). The degree of steatosis was classified as: S0-no steatosis, 201 transplants; S1-mild steatosis (<30%), 58 transplants; S2-moderate steatosis (30% to 60%), 18 transplants; and S3-severe steatosis (>60%), 17 transplants. The ischemia-reperfusion (I/R) injury, based on the maximum mean peak aspartate transferase in the first 72 posttransplant hours, tended to be greater as the degree of graft steatosis increased: S0, 1316; S1, 1985; S2, 2446; and S3, 2955 (P < .005 between S0 and S3). This greater initial hepatic dysfunction was correlated in the group with severe steatosis with a higher rate of severe renal failure requiring hemofiltration/hemodialysis: S0, 9%; S1, 15%; S2, 11%; and S3, 41% (P < .001); as well as with a higher early mortality (90 days): S0, 10%; S1, 21%; S2, 11%; and S3, 41% (P < .001). The Kaplan-Meier survival curve showed a significant difference (log-rank and Breslow) between the group with severe steatosis and the group with no steatosis (P = .002). We conclude that the degree of liver graft steatosis is an important determinant of I/R injury, although this progressive increase in the I/R injury with the degree of steatosis only had clinical repercussions in the case of severe steatosis.

Entities:  

Mesh:

Year:  2006        PMID: 17097969     DOI: 10.1016/j.transproceed.2006.08.077

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  22 in total

Review 1.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

Review 2.  Liver defatting: an alternative approach to enable steatotic liver transplantation.

Authors:  N I Nativ; T J Maguire; G Yarmush; D L Brasaemle; S D Henry; J V Guarrera; F Berthiaume; M L Yarmush
Journal:  Am J Transplant       Date:  2012-10-11       Impact factor: 8.086

Review 3.  CT and MR imaging evaluation of living liver donors.

Authors:  Federica Vernuccio; Susan A Whitney; Kadiyala Ravindra; Daniele Marin
Journal:  Abdom Radiol (NY)       Date:  2021-01

Review 4.  Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.

Authors:  Pallavi Pandey; Ankur Pandey; Mary Dillhoff; Carl Schmidt; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-18       Impact factor: 3.452

5.  Liver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosis.

Authors:  Yang Liu; Daizhan Zhou; Fang Zhang; Yanyang Tu; Yulei Xia; Hui Wang; Ben Zhou; Yi Zhang; Jingxia Wu; Xiang Gao; Zhishui He; Qiwei Zhai
Journal:  J Lipid Res       Date:  2012-01-09       Impact factor: 5.922

Review 6.  Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?

Authors:  Davide Ghinolfi; Erion Rreka; Daniele Pezzati; Franco Filipponi; Paolo De Simone
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-07

Review 7.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

8.  Influence of Kupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver.

Authors:  Koichi Ogawa; Tadashi Kondo; Takafumi Tamura; Hideki Matsumura; Kiyoshi Fukunaga; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

9.  Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.

Authors:  Justin D Ellett; Zachary P Evans; Carl Atkinson; Michael G Schmidt; Rick G Schnellmann; Kenneth D Chavin
Journal:  Liver Transpl       Date:  2009-09       Impact factor: 5.799

10.  The influence of retrograde reperfusion on the ischaemia-/reperfusion injury after liver transplantation in the rat.

Authors:  Hans Kern; Christian Bald; Thomas Brill; Falko Fend; Claus Hann von Weihern; Monika Kriner; Norbert Hüser; Stefan Thorban; Manfred Stangl; Edouard Matevossian
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.